Perkins Coie Trust Co Sells 105 Shares of Danaher Co. (NYSE:DHR)

Perkins Coie Trust Co trimmed its holdings in shares of Danaher Co. (NYSE:DHR) by 0.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,987 shares of the conglomerate’s stock after selling 105 shares during the period. Danaher comprises approximately 1.9% of Perkins Coie Trust Co’s investment portfolio, making the stock its 12th largest holding. Perkins Coie Trust Co’s holdings in Danaher were worth $4,186,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Rockland Trust Co. increased its holdings in Danaher by 3.7% in the 3rd quarter. Rockland Trust Co. now owns 4,744 shares of the conglomerate’s stock worth $659,000 after acquiring an additional 171 shares during the last quarter. Pacer Advisors Inc. increased its holdings in Danaher by 15.1% in the 3rd quarter. Pacer Advisors Inc. now owns 70,560 shares of the conglomerate’s stock worth $10,191,000 after acquiring an additional 9,275 shares during the last quarter. Legacy Private Trust Co. increased its holdings in Danaher by 9.9% in the 3rd quarter. Legacy Private Trust Co. now owns 26,140 shares of the conglomerate’s stock worth $3,776,000 after acquiring an additional 2,365 shares during the last quarter. Dubuque Bank & Trust Co. purchased a new stake in Danaher in the 3rd quarter worth about $225,000. Finally, Bogart Wealth LLC increased its holdings in Danaher by 6.2% in the 3rd quarter. Bogart Wealth LLC now owns 2,195 shares of the conglomerate’s stock worth $317,000 after acquiring an additional 129 shares during the last quarter. Institutional investors own 78.42% of the company’s stock.

DHR stock traded up $1.77 during mid-day trading on Friday, reaching $140.53. 721,930 shares of the company traded hands, compared to its average volume of 2,377,544. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.32 and a quick ratio of 1.91. The company has a market capitalization of $97.29 billion, a P/E ratio of 31.09, a P/E/G ratio of 2.27 and a beta of 0.94. Danaher Co. has a 52-week low of $94.59 and a 52-week high of $147.33. The company has a fifty day moving average price of $141.08 and a 200-day moving average price of $137.31.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.15 by $0.04. The business had revenue of $5.16 billion during the quarter, compared to analyst estimates of $5.09 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.15 EPS. As a group, analysts forecast that Danaher Co. will post 4.79 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date is Thursday, September 26th. Danaher’s payout ratio is presently 15.04%.

Several brokerages recently weighed in on DHR. Royal Bank of Canada set a $134.00 price objective on Danaher and gave the stock a “hold” rating in a report on Friday, July 19th. Needham & Company LLC reissued a “buy” rating and issued a $155.00 price objective (up previously from $142.00) on shares of Danaher in a report on Friday, July 19th. Piper Jaffray Companies lifted their price objective on Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a report on Thursday, July 18th. Wolfe Research set a $157.00 price objective on Danaher and gave the stock a “buy” rating in a report on Thursday, September 26th. Finally, ValuEngine lowered Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $145.92.

In other Danaher news, insider Brian W. Ellis sold 1,010 shares of Danaher stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $144.04, for a total transaction of $145,480.40. Following the completion of the transaction, the insider now owns 20,889 shares of the company’s stock, valued at approximately $3,008,851.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Angela S. Lalor sold 20,000 shares of Danaher stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $142.30, for a total value of $2,846,000.00. Following the transaction, the senior vice president now directly owns 58,515 shares of the company’s stock, valued at approximately $8,326,684.50. The disclosure for this sale can be found here. Insiders have sold a total of 177,202 shares of company stock valued at $25,175,829 in the last ninety days. Insiders own 11.40% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Recommended Story: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.